Table 1 Demographic and clinical information of 21 patients with disseminated NPC .
Patient No. | Age | Gender | Stage at initial diagnosis (TNM) | Distant metastasis site | PFS (Months) | Recurrence | Treatment outcome (PET3) | Survival |
|---|---|---|---|---|---|---|---|---|
1 | 57 | M | IVC (T3N3bM1) | Bone, LNs | 4 | Yes | SMD | |
2 | 57 | M | IVC (T3N3M1) | Bone | 5 | Yes | SMD | |
3 | 70 | M | III (T3N2M0) | Distant LNs | 5 | Yes | PMD | Dead |
4 | 37 | M | III (T3N2M0) | Bone, pleural, liver, LN | 5 | Yes | PMD | Dead |
5 | 57 | M | IVC (T1N3bM1) | Bone, liver, LNs | 5 | Yes | PMD | Dead |
6 | 62 | M | IVA (T4N2M0) | Liver, LN | 5 | Yes | PMD | |
7 | 38 | M | IVB (T2N3bM0) | Bone, LN | 6 | Yes | PMD | Dead |
8 | 51 | M | III (T3N1M0) | Bone, lung, LN | 4 | Yes | PMD | Dead |
9 | 45 | M | IVC (T3N3M1) | Bone, liver, LN | 5 | Yes | PMD | |
10 | 59 | F | IVC (T4N0M1) | Bone, liver | 11 PD | Yes | PMR | |
11 | 53 | M | IVC (T4N3M1) | Bone, presacral nodule | 12 PD | Yes | PMR | |
12 | 69 | M | IVA (T4N1M0) | Lung | 25 | No | PMR | Dead |
13 | 52 | M | III (T3N1M0) | Lung, LN | 15 In remission | No | PMR | |
14 | 38 | M | III (T3N1M0) | Bone, liver, lung | 10 PD | Yes | CMR | |
15 | 64 | F | IVC (T1N2M1) | Liver | 24 PD | Yes | CMR | |
16 | 59 | M | IVC (T3N3bM1) | Liver, lung | 8 PD | Yes | CMR | Dead |
17 | 50 | M | IVC (T3N2M1) | Liver | 9 PD | Yes | CMR | |
18 | 62 | M | IVC (T3N3M1) | Lung | 28 in remission | No | CMR | |
19 | 41 | F | III (T3N1M0) | Lung, LN | 17 in remission | No | CMR | |
20 | 63 | F | III (T1N2M0) | Bone, lung | 30 in remission | No | CMR | |
21 | 13 | F | IVC (T4N3M1) | Bone, liver | 18 in remission | No | CMR |
